Skip to main content
OpenTrials

Clinical trial condition

Cutaneous Melanoma

Explore clinical trials studying Cutaneous Melanoma. Study availability and eligibility vary by location and protocol.

58 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Cutaneous Melanoma trial results

Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

NCT07519655

Conditions
Cutaneous Melanoma, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Presbyterian/St Lukes Medical Center Denver, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute- Pharmacy Nashville, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Recruiting

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

NCT07621614

Conditions
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, +16 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
  • East Tennessee Childrens Hospital Knoxville, Tennessee, United States
  • Saint Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

NCT07600476

Conditions
Basal Cell Carcinoma of Skin, Carcinoma, Carcinoma, Basal Cell, +18 more
Locations
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
  • Fachklinik Hornheide Münster, North Rhine-Westphalia, Germany
  • Klinikum der Ludwig-Maximilians-Universität München, Klinik und Poliklinik für Dermatologie und Allergologie Munich, Bavaria, Germany
View Trial Details
Recruiting

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

NCT04855435

Conditions
Advanced Solid Tumor, Cutaneous Melanoma, Eye Diseases, +21 more
Locations
  • Herlev and Gentofte Hospital, Center for Cancer Research Herlev, Denmark
  • Institut Catalá de Oncologia - Hospital Duran i Reynals. Barcelona, Spain
  • Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD) Madrid, Spain
  • Centro Integral Oncológico Clara Campal (CIOCC) Madrid, Spain
View Trial Details
Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations
  • Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
  • Washington University St Louis, Missouri, United States
View all 18 locations
View Trial Details
Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

NCT03947385

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +27 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • San Francisco Oncology Associates San Francisco, California, United States
  • SCRI - Denver Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View all 15 locations
View Trial Details

Related conditions